Document is current
Any future updates will be listed below
-
Authors
Abdel-Fatah, Tarek M. A.
Broom, Reuben J.
Lu, Jun
Moseley, Paul M.
Huang, Baiqu
Li, Lili
Liu, Suling
Chen, Longxin
Ma, Runlin Z.
Cao, Wenming
Wang, Xiaojia
Li, Yan
Perry, Jo K.
Aleskandarany, Mohammed
Nolan, Christopher C.
Rakha, Emad A.
Lobie, Peter E.
Chan, Stephen Y. T.
Ellis, Ian O.
Hwang, Le-Ann
Lane, David P.
Green, Andrew R.
Liu, Dong-Xu
- License Information
-
More Information
Article History
Received: 18 October 2018
Revised: 27 January 2019
Accepted: 29 January 2019
First Online: 28 February 2019
Competing interests
: D.-X.L., T.M.A.A.-F., J.K.P., J.L., B.H., S.Y.T.C., A.R.G., and I.O.E. are named inventors on a PCT patent application PCT/NZ/2013/000188 and patent applications NZ603056, NZ616981, CN201380063947, AU2013332512, EP2013846652 and US15/103581; D.-X.L. and R.Z.M. are applicants for the applications PCT/NZ/2013/000188 and NZ616981; and D.-X.L. is the applicant for the application NZ603056. The remaining authors declare no competing interests.
: The data that support the findings of this study and materials described are available from the corresponding author upon reasonable request. Some restrictions may apply.
: All patients were consented as per hospital standard of care. This study was approved by the Hospital Research and Innovations Department and the Nottingham Research Ethics Committee 2 under the title "Development of a molecular genetic classification of BC" (REC Reference No C202313).
: This work was supported by the Breast Cancer Foundation New Zealand (to D.-X.L. & R.J.B., no grant number), the New Zealand Breast Cancer Cure (to D.-X.L., no grant number), the Health Research Council of New Zealand (14/704 to D.-X.L., R.J.B., T.M.A.A.-F., J.L., A.R.G., S.Y.T.C. & I.O.E.), the Auckland Medical Research Foundation (1113022 to D-X.L.), the Margaret Morley Medical Trust (to D.-X.L., no grant number), the Maurice & Phyllis Paykel Trust (to D.-X.L., no grant number), the Kelliher Charitable Trust (to D.-X.L., no grant number), the Lottery Health Research of New Zealand (340942 to D.-X.L., I.O.E., A.R.G., S.Y.T.C. & T.M.A.A.-F.), the Biopharma Programme of the University of Auckland (to D.-X.L., no grant number), and the Shenzhen Development and Reform Commission Subject Construction Project (2017/1434 to P.E.L).
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
